Progress: PTT Group jointly invests in NAM to develop medical devices
18 May – 1 year anniversary at PTT Plc. by affiliated companies "Innobic Asia" jointly invested with Nam Vivat Medical Corporation Public Company Limited (NAM), formerly known as Nam Vivat Karnchang 1992, a Thai company, to jointly develop innovative medical devices to penetrate the global market.
Dr. Buranin Rattanasombat, Chief Operating Officer, New Business and Infrastructure Group, PTT Public Company Limited and President of Innobic (Asia) and Mr. Virot Chaiterdkiat Chief Executive Officer Plc. Namvivat Medical Corporation (NAM) stated that after Innobic came to enhance Namvivat's strengths by purchasing capital increase shares last month May last year The total value is more than 800 million baht, or equivalent to 17.65% of the shareholding, it helps to support the business drive of Namwiwat. Both support with emerging diseases and complexity of medical equipment from the emergence of COVID-19 Causing people around the world to pay attention to their health More self-defense This is a good opportunity to enter the medical device market. both in the ASEAN region and in the global market
Numwiwat's main business is manufacturing and distributing leading sterilization equipment and medical equipment. The main customers are hospitals and government agencies. accounted for more than 90%, including being a factory certified by international standards which Innobic has invested will strengthen the group's business operations PTT in the production of medical devices and jointly expand the market to foreign countries Including launching new products such as equipment used in operating rooms, emergency rooms and intensive care units (ICU). Has a growth rate of 10.45% over the past 5 years, most of which still rely mainly on imports from abroad. This cooperation is therefore in line with the business direction of PTT Group. Innobic will join with potential partners. combine expertise expand knowledge and strengthen each other to aim to improve the quality of life for Thai people Promote stability for the country's public health system in terms of medicine. medical equipment materials and healthy food ready to push Thailand to be the center of health in the future
In this regard, Namvivat Medical Public Company Limited has submitted a registration statement and draft prospectus to the SEC for the initial public offering (IPO) of not more than 181 million shares or 25.86%. of the number of ordinary shares, par value of 0.50 baht/share and will be listed on the Stock Exchange of Thailand (SET). The purpose of raising funds is to invest in a new manufacturing plant of 500 million baht, invest in the development of research and development centers for medical device products, invest or co-invest. in other companies operating the medical device business or have innovations that promote business operations of the company And as working capital in the business.-
Source: Thai News Agency